darifenacin hydrobromide
post date: dec 19,2021 expiry date: jun 17,2022 detailed description: cas no. :133099-07-7 darifenacin hydrobromide133099-07-7 cas registry number: 133099-07-7 synonyms: ;{1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl]-3-pyrrolidnyl}-2,2-diphenylacetamide hydrobromide;darifenacin hbr;2-{(3s)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide hydrobromide (1:1);2-{1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide hydrobromide (1:1); molecular formula: c28h31brn2o2 molecular weight: 507.4619 molecular structure:
darifenacin hydrobromide
post date: dec 07,2021 expiry date: jun 05,2022 detailed description: cas no. :133099-07-7 darifenacin hydrobromide133099-07-7 cas registry number: 133099-07-7 synonyms: ;{1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl]-3-pyrrolidnyl}-2,2-diphenylacetamide hydrobromide;darifenacin hbr;2-{(3s)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide hydrobromide (1:1);2-{1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide hydrobromide (1:1); molecular formula: c28h31brn2o2 molecular weight: 507.4619 molecular structure:
darifenacin hydrobromide
post date: dec 02,2021 expiry date: may 31,2022 detailed description: cas no. :133099-07-7 cas registry number: 133099-07-7 synonyms: ;{1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl]-3-pyrrolidnyl}-2,2-diphenylacetamide hydrobromide;darifenacin hbr;2-{(3s)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide hydrobromide (1:1);2-{1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide hydrobromide (1:1); molecular formula: c28h31brn2o2 molecular weight: 507.4619 molecular structure:
